Serum prolactin level and lactate dehydrogenase activity in patients with epileptic and nonepileptic seizures A cross-sectional study

Abstract

It is important to diagnose epilepsy in a timely and accurate manner, and also to distinguish it from non-epileptic conditions. The present study was aimed at determining postictal serum prolactin levels and lactate dehydrogenase (LDH) activities in patients with new-onset seizure admitted to the emergency department in order to assess whether they could be used in the differentiation of epileptic seizure (ES) from nonepileptic seizure (NES). Eighty-five patients were included prospectively in this study. Patients were divided into 2 groups with respect to epilepsy diagnosis, and the final groups were comprised of 36 patients with ES and 49 patients with NES. Blood samples were obtained within 1hour of seizure. No significant differences between groups were observed in prolactin levels and in the percentage of patients with abnormal prolactin level (P=.569 and .239, respectively). The median LDH activity was significantly higher in those with ES compared with those with NES (P=.031). The percentage of patients with elevated LDH levels was similar between 2 groups (P=.286). This was the first study to examine LDH activities in terms of its role in differentiation of seizure origin in the postictal period in patients hospitalized with seizure. Our study demonstrated that serum LDH activities within 1hour after the seizure appear to be increased in patients with ES compared with those with NES, suggesting the potential role of LDH activities as a diagnostic tool in distinction of seizure types. Our study supports the hypothesis that LDH-antagonists may have a role in the management of seizure and epilepsy.